American National Bank Acquires 151 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

American National Bank increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 750 shares of the company’s stock after purchasing an additional 151 shares during the quarter. American National Bank’s holdings in GE HealthCare Technologies were worth $58,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First Command Advisory Services Inc. lifted its holdings in GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares during the period. OFI Invest Asset Management bought a new position in GE HealthCare Technologies in the third quarter valued at about $26,000. ORG Partners LLC lifted its holdings in GE HealthCare Technologies by 174.2% in the third quarter. ORG Partners LLC now owns 425 shares of the company’s stock valued at $29,000 after acquiring an additional 270 shares during the period. Fortitude Family Office LLC bought a new position in GE HealthCare Technologies in the fourth quarter valued at about $29,000. Finally, Turtle Creek Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the fourth quarter valued at about $30,000. 82.06% of the stock is owned by institutional investors.

Insider Transactions at GE HealthCare Technologies

In related news, insider Frank R. Jimenez bought 1,315 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the acquisition, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Jan Makela sold 66,955 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the completion of the sale, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at approximately $5,165,395.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Frank R. Jimenez purchased 1,315 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the purchase, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC traded up $0.55 during trading on Friday, hitting $81.86. 1,321,025 shares of the stock traded hands, compared to its average volume of 3,060,621. The company has a market capitalization of $37.37 billion, a P/E ratio of 23.94, a price-to-earnings-growth ratio of 2.92 and a beta of 1.26. The firm has a 50-day simple moving average of $86.07 and a 200-day simple moving average of $80.08. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting the consensus estimate of $0.90. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.85 EPS. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date was Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Bank of America decreased their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Citigroup raised their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Evercore ISI raised their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. HSBC began coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their target price for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $94.80.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.